FSHR and renal cell carcinoma: Therefore, we investigated the differential expression of two molecular markers, VEGFR-1 and FSHR, between sunitinib and control groups of mice engrafted with patient-derived xenografts (PdX) of RCC during 4 weeks of treatment.